Clinical significance and the difference between programmed death-1 ligand-1 and ligand-2 in patients with esophageal cancer

被引：0
|
作者：
Okadome, Kazuo [1 ]
Baba, Yoshifumi [1 ]
Yagi, Taisuke [1 ]
Kiyozumi, Yuki [1 ]
Eto, Kojiro [1 ]
Hiyoshi, Yukiharu [1 ]
Nagai, Yohei [1 ]
Ishimoto, Takatsugu [1 ]
Iwatsuki, Masaaki [1 ]
Iwagami, Shiro [1 ]
Miyamoto, Yuji [1 ]
Yoshida, Naoya [1 ]
Baba, Hideo [1 ]
机构：
[1] Kumamoto Univ, Kumamoto, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-4123
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4123
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
    Jaafar, Jaafar
    Fernandez, Eugenio
    Alwan, Heba
    Philippe, Jacques
    ENDOCRINE CONNECTIONS, 2018, 7 (05): : R196 - R211
  • [32] Recent advances of immunotherapy in lung cancer: anti-programmed cell death-1/programmed death ligand-1 antibodies
    Yang, Lu-Lu
    Wu, Yi-Long
    LUNG CANCER MANAGEMENT, 2014, 3 (02) : 175 - 190
  • [33] Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
    Zhang, Ni
    Tu, Jingyao
    Wang, Xue
    Chu, Qian
    IMMUNOTHERAPY, 2019, 11 (05) : 429 - 441
  • [34] Programmed Death-1/Programmed Death Ligand-1 Inhibitor-Related Pneumonitis and Radiographic Patterns Reply
    Naidoo, Jarushka
    Iyriboz, Tunc
    Cunningham, Jane
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (14) : 1629 - +
  • [35] Programmed Cell Death-1 and Programmed Cell Death Ligand-1 in Childhood Acute B-Lymphoblastic Leukemia: Expression and Significance as Biomarker
    Allam, Ahmed Ahmed
    Ahmed, Heba A.
    Hassan, Mohammad Ahmad
    Khaled, Safaa A. A.
    Shibl, Azza
    Osman, Amira Mahmoud
    Ali, Nada Mohamed Rafat
    Ahmed, Nesma Mokhtar
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2025,
  • [36] Expression and Clinical Significance of Programmed Death Ligand-1 and Nucleophosmin in Triple-Negative Breast Cancer
    Jiang, Yiting
    Lian, Yuane
    Chen, Hu
    Huang, Jianping
    Zhang, Shihan
    Yang, Yinghong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (06): : 3283 - 3287
  • [37] Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer: A meta-analysis of the literature
    Yu, Weiwei
    Guo, Yanmei
    MEDICINE, 2018, 97 (30)
  • [38] Clinicopathological significance and prognostic implication of programmed death-1 ligand 2 expression in colorectal cancer
    Pyo, Jung-Soo
    Song, Byoung Kwan
    Chung, Kwang Hyun
    Oh, IlHwan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (03): : 276 - 283
  • [39] Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
    Chen, Zhifang
    Pang, Nannan
    Du, Rong
    Zhu, Yuejie
    Fan, Lingling
    Cai, Donghui
    Ding, Yan
    Ding, Jianbing
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [40] Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study
    Chen, Yan-bin
    Mu, Chuan-Yong
    Huang, Jian-An
    TUMORI, 2012, 98 (06) : 751 - 755
12345